1611.10 17.70 (1.11%)

Near 52W Low of ₹1553.05

1.0M NSE+BSE Volume

NSE 11 Sep, 2025 1:19 PM (IST)

US FDA Classification
US FDA flags Sun Pharma’s Halol facility as OAI, citing non-compliance with CGMP standards See details


Sun Pharmaceutical Industries Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SUNPHARMA, BSE:524715 Sun Pharmaceutical Industries Ltd.

1586 Votes:
Buy 75.35%
Sell 15.76%
Hold 8.89%
BUY
SELL
HOLD